Yuyao Biotech
Yuyao Biotech develops AI-driven therapeutics to address major unmet clinical needs in hematological tumors, neurodegenerative disorders, and autoimmune diseases. The company uses artificial intelligence and modern drug-creation technologies to discover and optimize novel drug candidates. Yuyao operates as an R&D-focused biotechnology company applying computational biology, machine learning, and preclinical translational science. Its platform supports preclinical programs and potential partnerships with clinical development organizations and pharma. The company targets clinical markets for therapeutics that address serious unmet medical needs.
Yuyao Biotech
Yuyao Biotech develops AI-driven therapeutics to address major unmet clinical needs in hematological tumors, neurodegenerative disorders, and autoimmune diseases. The company uses artificial intelligence and modern drug-creation technologies to discover and optimize novel drug candidates. Yuyao operates as an R&D-focused biotechnology company applying computational biology, machine learning, and preclinical translational science. Its platform supports preclinical programs and potential partnerships with clinical development organizations and pharma. The company targets clinical markets for therapeutics that address serious unmet medical needs.